Rabi Tawil

Professor Emeritus of Neurology · University of Rochester Medicine

Credentials: · · ·

History

Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Center
National Institute of Neurological Disorders and Stroke · P50
Project lead · $1.1M · University of Rochester
2003–2024
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
National Institute of Neurological Disorders and Stroke · U01
Contact PI · $3.2M · University of Rochester
2017–2023
Phase II Trial of Arimoclomol in IBM
Food and Drug Administration · R01
PI · $1.6M · University of Kansas Medical Center
2015–2022
The Pathogenesis of Facioscapulohumeral Muscular Dystrophy
National Institute of Neurological Disorders and Stroke · P01
Project lead · $2M · Fred Hutchinson Cancer Research Center
2014–2021

Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)
Principal investigator · Recruiting
University of Kansas Medical Center
2020–2028
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
Principal investigator · Active not recruiting
University of Kansas Medical Center
2018–2027
Hyper- and Hypokalemic Periodic Paralysis Study
Principal investigator · Completed · Phase 3
University of Rochester
2007–2013
Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
Sub-investigator · Recruiting
University of Rochester
2000–2028